B+
Bull case
30%
Probability
Target price
$96.00
Analysis reference price unavailable
Analysis 2026-05-09 · RankAlpha Sentiment Codex
MET
MetLifeCNYSE / Insurance
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
45%
Probability
Target price
$90.00
Analysis reference price unavailable
Analysis 2026-05-09 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$72.00
Analysis reference price unavailable
Analysis 2026-05-09 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-05-09
Recent news sentiment (30D)
+26.6
Positive
Company
-
Unavailable
Macro
+26.6
Positive
Pulse
-
Unavailable
Weekly research (10D)
-32.0
Negative
Sentiment proxy
+52.7
Score
AI commentary
Tone is mixed-positive. Primary company materials support a strong operating quarter and solid capital position, but checked post-print coverage emphasized an EPS beat paired with a revenue miss and a modest negative immediate stock reaction. Headline buzz is high because this is a T+3 earnings follow-up, but delayed analyst revision visibility was limited in checked sources, which keeps this as a cautious monitoring-style positive rather than a high-conviction upgrade.
RankAlpha Sentiment Codex - 2026-05-09
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-06event1Q26 earnings and capital return reset the near-term tapeMedium impact
MetLife's May 6 earnings package showed adjusted EPS up 23% to $2.42, adjusted earnings up 18% to $1.586B, adjusted PFOs excluding PRT up 10% to $13.3B, direct expense ratio at 11.9% versus the 12.1% full-year target, and over $1.1B returned via buybacks and dividends; this keeps the post-print debate centered on execution versus a revenue-miss narrative [#8-K-2026-05-06].
2026-05-20catalystT+3 estimate digestion after EPS beat but revenue missMedium impact
Checked post-print secondary coverage framed the quarter as an EPS beat versus consensus but with revenue below expectations and a modest negative immediate stock reaction, so the next 1-2 weeks matter for whether estimate revisions and target maintenance outweigh the top-line miss.
2026-08-05catalystExpense discipline, liquidity, and MIM scaling support medium-term reratingHigh impact
Management highlighted $3.9B of holding-company cash at the top of target range, 379% RBC versus a 360% target, MIM adjusted earnings up 68%, and AUM up 22% helped by PineBridge, while office and commercial mortgage exposures were shown as reduced versus year-end 2023; if these remain intact, MET can defend a higher multiple than a pure spread-and-mortality story [#8-K-2026-05-06][#10-Q-2026-05-07].
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-09 • Updated nightlySource: Internal modelMethodology